Open AccessHealth Care Costs of Alzheimer’s and Related Dementias Within a Medicare Managed Care Provider
Author(s) -
Paul Fishman,
Lesley White,
Bailey Ingraham,
Sungchul Park,
Eric B. Larson,
Paul K. Crane,
Norma B. Coe
Publication year - 2020
Publication title -
medical care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.632
H-Index - 178
eISSN - 1537-1948
pISSN - 0025-7079
DOI - 10.1097/mlr.0000000000001380
Subject(s) - medicine , dementia , pharmacy , minimum data set , health care , gerontology , ambulatory care , cohort study , ambulatory , retrospective cohort study , cohort , indirect costs , medline , emergency medicine , disease , family medicine , nursing homes , nursing , surgery , business , pathology , accounting , political science , law , economics , economic growth
Although one third of Medicare beneficiaries are enrolled in Medicare Advantage (MA) plans, there is limited information about the cost of treating Alzheimer disease and related dementias (ADRD) in these settings.